A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Antiobesity Activity of Liraglutide on High Fat Diet-Induced Obesity in Wistar Rats
2017
Current Research in Diabetes & Obesity Journal
Liraglutide is a glucagon like peptide-1 (GLP-1) analogue. GLP-1 is a potent inhibitor of motility and gastric emptying and has also been shown to inhibit gastric acid secretion. The inhibition of gastric emptying leads to decreased food intake and reduced body weight. The aim of the present study was to investigate the antiobesity effect of the Liraglutide on high fat diet (HFD) induced obesity in Wistar rats. Obesity was induced by oral feeding of HFD for six weeks. The antiobesity effect of
doi:10.19080/crdoj.2017.03.555602
fatcat:ceapxn5knzh6tinxpk5fuohwki